Table 1.
ITC analyses of binding between AcrIF7 and Cas8f–Cas5f mutantsa
AcrIF7 | Cas8f–Cas5f | K D (nM) | N | ΔG (kcal/mol) | ΔH (kcal/mol) | TΔS (kcal/mol) |
---|---|---|---|---|---|---|
WT | WT | 46 ± 14 | 0.78 ± 0.00 | –10.0 ± 0.2 | –17.1 ± 0.2 | –7.1 ± 0.3 |
D13K | WT | 2451 ± 528 | 0.72 ± 0.02 | –7.7 ± 0.1 | –14.2 ± 0.6 | –6.5 ± 0.7 |
E18K | WT | 49 ± 4 | 0.88 ± 0.00 | –10.0 ± 0.1 | –19.6 ± 0.1 | –9.6 ± 0.1 |
E22K | WT | 50 ± 19 | 0.75 ± 0.01 | –10.0 ± 0.2 | –15.6 ± 0.3 | –5.6 ± 0.4 |
D28K/D29K | WT | 179 ± 25 | 0.75 ± 0.00 | –9.2 ± 0.1 | –12.9 ± 0.1 | –3.7 ± 0.2 |
E33K/E34K | WT | 4854 ± 1053 | 0.90 ± 0.04 | –7.3 ± 0.1 | –9.5 ± 0.6 | –2.3 ± 0.6 |
E46K/E47K | WT | 46 ± 11 | 0.80 ± 0.00 | –10.0 ± 0.2 | –17.0 ± 0.2 | –7.0 ± 0.2 |
D57K | WT | 333 ± 116 | 0.77 ± 0.02 | –8.9 ± 0.2 | –12.7 ± 0.4 | –3.8 ± 0.4 |
WT | K29E(Cas8f) | 327 ± 43 | 0.83 ± 0.01 | –8.8 ± 0.1 | –14.5 ± 0.2 | –5.7 ± 0.2 |
D13K | K29E(Cas8f) | N.B.b | N.B. | N.B. | N.B. | N.B. |
E33K/E34K | K29E(Cas8f) | N.B. | N.B. | N.B. | N.B. | N.B. |
WT | K248E(Cas8f) | 1873 ± 132 | 0.78 ± 0.01 | –7.8 ± 0.0 | –16.0 ± 0.2 | –8.2 ± 0.2 |
D13K | K248E(Cas8f) | N.B. | N.B. | N.B. | N.B. | N.B. |
D28K/D29K | K248E(Cas8f) | N.B. | N.B. | N.B. | N.B. | N.B. |
E33K/E34K | K248E(Cas8f) | N.B. | N.B. | N.B. | N.B. | N.B. |
D57K | K248E(Cas8f) | N.B. | N.B. | N.B. | N.B. | N.B. |
AcrIF2c | WT | 7.2 ± 2.0 | 0.84 ± 0.00 | –11.0 ± 0.2 | –22.2 ± 0.1 | –11.1 ± 0.2 |
aRaw ITC data are provided in Supplementary Figure S5.
bNo binding: Integrated heats from the measurement were not sufficient to constrain the least squares fit derived from a one-site binding model for the titration.
cRef. (24).